UI Hospitals and Clinics

Clinical Trial Details

Short Title
Official Title
A Phase III Randomized Trial for the Treatment of Newly Diagnosed Supratentorial PNET and High Risk Medulloblastoma in Children <36 Months Old With Intensive Induction Chemotherapy With Methotrexate Followed by Consolidation With Stem Cell Rescue Versus the Same Therapy Without Methotrexate

Participants in this study are children under the age of three that have been diagnosed with either high risk medulloblastoma or a primitive neuroectodermal tumor. The purpose of this study is to compare two treatment regimens to see which one is a better treatment method. Approximately 4 children will take part in this study conducted by researchers at the University of Iowa. Study involvement will last approximately 6 months.

Start Date
May 13, 2009
End Date
May 13, 2019
Gender Preference
Age Group
0 - 3 years
Principal Investigator
Ayman El-Sheikh, MD
Contact Info

Julie de la Garza, (319) 356-3749

Hematology/ Oncology
200903733 ; cancer ; El-Sheikh ; High Risk Medulloblastoma ; Medulloblastoma ; pediatric ; primitive neuroectodermal tumor (PNET) ;

We welcome your feedback! Please help us improve your experience on our website by completing a brief survey.